| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |